Stem cell biologist Takanori Takebe of Yokohama City University in Japan successfully grew a small rudimentary liver while at the RIKEN Center for Developmental Biology in Kobe, researcher Yoshiki Sasai and his colleagues directed “retinal precursor cells” to develop into an the optic cup of the eye. Takebe said “a more developed version of the liver could eventually be used for long-term organ replacement, as well as serving as a short-term graft for patients whose damaged native livers are expected to recover.” Both the liver research and the optical tissue regeneration are examples of how advances in directing cells to differentiate will accelerate the application of stem cell treatments.
As this research demonstrates, the field of regenerative medicine is making great strides in research and clinical applications that is ushering a paradigm shift in the field of medicine. As these regenerative treatments become available, the best stem cells to use will be autologous stem cells [the patient’s own stem cells] as this eliminates the risk of rejection and the need for immuno-suppression drugs.
To view the full article, click here
The future of Regenerative Medicine is now™.